Provided by Tiger Trade Technology Pte. Ltd.

Qualigen Therapeutics, Inc.

3.21
0.0000
Volume:- -
Turnover:1.18M
Market Cap:16.56M
PE:-0.49
High:3.21
Open:3.21
Low:3.21
Close:3.21
52wk High:8.81
52wk Low:1.61
Shares:5.16M
Float Shares:2.03M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4964
EPS(LYR):-17.5526
ROE:-2140.55%
ROA:-171.67%
PB:-3.73
PE(LYR):-0.18

Loading ...

Company Profile

Company Name:
Qualigen Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.